⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29222594 | 0.83 | — | — | |
| SCHEMBL8450102 | 0.78 | — | — | |
| SCHEMBL9325588 | 0.72 | — | — | |
| SCHEMBL11505001 | 0.72 | — | — | |
| SCHEMBL8863700 | 0.70 | — | — | |
| SCHEMBL17049101 | 0.67 | — | — | |
| SCHEMBL13963806 | 0.67 | — | — | |
| SCHEMBL9591782 | 0.65 | — | — | |
| SCHEMBL13974149 | 0.65 | — | — | |
| SCHEMBL8984853 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015138794-A9 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2015138794-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2015-09-17 | — | — | WO | claimed |
| WO-2015138786-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2015-09-17 | — | — | WO | claimed |
| CN-118140318-A | Negative electrode aqueous slurry composition for lithium ion electric storage device | PPG工业俄亥俄公司 | 2024-06-04 | — | — | CN | disclosed |
| US-9622991-B2 | Hematopoietic growth factor mimetic small molecule compounds and their uses | LIGAND PHARMACEUTICALS INC. (US) | 2017-04-18 | — | — | US | disclosed |